Cyclerion Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	$3.32M N/A	$297K -91.05%	$0 -100%	Avg: $2.03M Low: $2.03M High: $2.03M avg. 0%	Avg: $90.33M Low: $90.33M High: $90.33M avg. 4334.51%
Net Income % change YoY	$-51.66M N/A	$-43.78M 15.25%	$-21.01M 52.00%	Avg: $-78.08M Low: $-78.08M High: $-78.08M avg. -271.58%	Avg: $-47.22M Low: $-47.22M High: $-47.22M avg. 39.52%
EBITDA % change YoY	$-53.84M N/A	$-44.30M 17.70%	$-12.59M 71.57%	Avg: $-1.22M Low: $-1.22M High: $-1.22M avg. 90.29%	Avg: $-54.19M Low: $-54.19M High: $-54.19M avg. -4334.51%
EPS % change YoY	-$26.4 N/A	-$20.15 23.67%	-$8.99 55.38%	Avg: -$33.4 Low: -$33.4 High: -$33.4 avg. -271.52%	Avg: -$20.2 Low: -$20.2 High: -$20.2 avg. 39.52%
Operating Expenses % change YoY	$57.63M N/A	$44.66M -22.49%	$9.64M -78.40%	Avg: $31.05M Low: $31.05M High: $31.05M avg. 221.92%	Avg: $1.37B Low: $1.37B High: $1.37B avg. 4334.51%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -116.03% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -78.08M, average is -78.08M and high is -78.08M.

Wall Street analysts forecast annual average revenue growth of 2167.25% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $2.03M, average is $2.03M and high is $2.03M.

Wall Street analysts forecast annual average earnings growth of -116.00% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$33.4, average is -$33.4 and high is $-33.4.